Related Experiment Videos
Insights
Tuberous sclerosis complex (TSC) is a genetic disorder affecting multiple organs, often diagnosed in childhood via skin lesions and seizures. Early diagnosis and adherence to international guidelines are crucial for managing this hamartoma-causing condition.
Area of Science:
- Genetics
- Dermatology
- Neurology
- Pediatrics
Background:
- Tuberous sclerosis complex (TSC) is a genetic disorder affecting multiple organ systems.
- It is characterized by hamartomas (benign tumors) in the brain, heart, kidneys, skin, and other organs.
- TSC is typically identified in infants and children through characteristic skin lesions, seizures, and organ involvement.
Purpose of the Study:
- To provide an overview of Tuberous Sclerosis Complex (TSC).
- To highlight the importance of accurate diagnosis for patient management.
- To reference established international guidelines for diagnosis, surveillance, and treatment.
Main Methods:
- Review of existing literature and clinical observations.
- Reference to the International Tuberous Sclerosis Complex Consensus Group guidelines.
- Discussion of diagnostic criteria and management strategies.
Main Results:
- TSC is caused by mutations in TSC1 or TSC2 genes, affecting hamartin and tuberin protein complex function.
- The hamartin-tuberin complex regulates cellular hyperplasia, and its dysfunction leads to hamartoma formation.
- Diagnosis relies on characteristic clinical features and genetic testing.
Conclusions:
- Accurate diagnosis of TSC is essential for timely and appropriate surveillance and treatment.
- Management involves symptomatic treatment and specific interventions for clinical manifestations.
- Adherence to international consensus guidelines ensures comprehensive patient care.
Abstract:
Tuberous sclerosis complex (TSC) is a neurocutaneous syndrome that can present at any age and can affect multiple organ systems. This disorder is usually identified in infants and children based on characteristic skin lesions, seizures, and cellular overgrowth or hamartomas in the heart, brain, and kidneys. Tuberous sclerosis complex is a genetic disorder caused by a mutation in either the TSC1 or TSC2 gene leading to dysfunction of hamartin or tuberin, respectively. Hamartin and tuberin form a protein complex that helps regulate cellular hyperplasia. Accurate diagnosis is essential in implementing appropriate surveillance and treatment to patients with this disorder. Specific guidelines for diagnosis, surveillance, and management have been proposed by the International Tuberous Sclerosis Complex Consensus Group. Treatment of tuberous sclerosis complex is in part symptomatic; however, for certain clinical manifestations, specific treatments may be indicated. [Pediatr Ann. 2017;46(4):e166-e171.].